Background: Rupture of silicone gel breast implants is a rare occurrence but remains one of the key surgical concerns. The objective of this article was to provide visibility and information on trends for the impact that patient and surgical characteristics play in the occurrence of rupture. Objectives: Examine trends in surgical techniques to better understand the etiology of implant rupture. Methods: Analysis was based on Sientra's prospective, open-label, U.S.-based clinical study of High-Strength Cohesive silicone breast implants. Patient and surgical characteristics were compared between ruptured and intact implants. Results: The subset of data used for this analysis included 1792 implants in 935 primary and revision augmentation patients implanted by 31 plastic surgeons, with an average follow-up of 6.6 years. The results confirm that rupture remains a rare adverse event. Overall, the rupture prevalence for this study was 2.4%. Rupture prevalence was lower among textured devices (0.8%) compared to smooth devices (3.8%). The prevalence of rupture was 7.8% among devices placed with a transaxillary incision site compared to 1.6% and 3.0% when placed with an inframammary or periareolar incision site, respectively. Rupture was reported in 5.5% of the devices that received steroid pocket irrigation, compared to 1.8% of the devices that did not. Conclusions: Although ruptures in the Sientra study with the High-Strength Cohesive silicone gel implants were an uncommon occurrence, the authors were able to identify strong trends for the association of certain surgical factors and characteristics. The results show among other factors that an inframammary approach and a textured device were found to be protective against rupture.
Rupture of silicone gel breast implants remains one of the least understood complications following breast augmentation. The etiology is variable and includes such modes as fold fatigue and flex fatigue, as well as iatrogenic occurrences during surgery. Silent rupture presents a challenging situation for plastic surgeons and often requires sophisticated imaging modalities. Although rupture is relatively low in terms of actual occurrence, it is one of patients' key concerns when considering breast implant surgery.
This study incorporates data obtained from the Sientra clinical trial based in the United States, evaluating women following primary and revision breast augmentation. The goal of this analysis was to examine trends in surgical techniques and to further understand the etiology and diagnosis of silicone gel implant rupture.
METHODS

Patients
Analysis was based on Sientra's Food and Drug Administrationapproved large prospective, open-label, U.S.-based clinical study of its high-strength cohesive silicone gel breast Dr Haws is a plastic surgeon in private practice in Nashville, Tennessee. Dr Alizadeh is a plastic surgeon in private practice in Great Neck, New York. Dr Kaufman is a plastic surgeon in private practice in Folsom, California. implants. Patients were enrolled based on defined inclusion and exclusion criteria 1 and informed consent was obtained for all patients by the study surgeons under an IRB approved protocol. The subset of data for this analysis included 1792 implants in 935 primary and revision augmentation patients implanted by 31 plastic surgeons (median 63 implants).
Data Collection
All patients were monitored per protocol by their surgeons at postoperative intervals that included six weeks, one-year, and annually through 10 years of study follow-up. The occurrence of rupture was documented on explant and MRI case report forms. Fifty-five percent of the analysis population was enrolled in an additional MRI substudy and underwent MRI scans every two years. The distribution of scans in the MRI cohort was: no MRIs (5%), 1-2 MRIs (43%), [3] [4] MRIs (49%), and 5-6 MRIs (3%). MRI scans were independently interpreted by two radiologists. One was a local radiologist and the other was a blinded central expert radiologist. Both radiologists reported their findings and these findings were classified into three categories: no evidence of rupture, indeterminate evidence of rupture, and definitive evidence of rupture. Although not required by protocol, some non-MRI cohort patients included in this analysis underwent MRIs.
Patient and device-related characteristics were collected on the study case report forms. Patient characteristics included: age at implantation, body mass index, and indication for surgery ( primary augmentation or revisionaugmentation). Device characteristics included type of implant surface (textured or smooth), device size (cc), and if round or shaped. Surgery-related characteristics included: method of anesthesia (general or local), incision site (transaxillary, periareolar or inframammary), surgical facility (surgeon's office or hospital/surgical center), and implant pocket placement (submuscular or subglandular). Submuscular device placement included various dual-plane techniques. Some of the subglandular devices were placed in the subfascial position. 2 The various irrigation solutions included antibiotic, dilute povidone-iodine, or steroid solutions alone or in combination.
Postoperative characteristics collected were capsular contracture formation prior to rupture as well as the recommendation of a surgical bra and/or massage protocols.
Device Retrieval
Retrieval analysis was performed on explanted devices that were returned through the study. Extensive mechanical and physical testing is performed along with microscopic analysis, which includes scanning electronic microscopy when required. Ruptures are generally categorized into three main types of shell failure: flex fatigue/fold flaw failure, surgical instrument damage, and unknown local stress (Figure 1 ).
Flex fatigue/fold flaw can be a cause or result of shell failure and is characterized by "feather lines" on the surface of the explanted device, which can advance to pronounced surface cracking. Surgical instrument damage is typically characterized by parallel striation lines on the cut surface of the shell, caused by a surgical instrument such as a scalpel or needle. Local stress of unknown origin is caused by an unknown stress applied to the implant that causes shell failure; these types of rupture do not have any obvious signs of another failure cause.
Statistical Methods
All devices were categorized as either ruptured or nonruptured. Categorization of rupture was defined as rupture at explantation or MRI evidence of definitive rupture by both radiologists. Categorization of non-rupture was defined as a non-ruptured device at explantation or MRI evidence of an intact implant by both radiologists. Devices with inconsistent or indeterminate MRI results that were not yet explanted were excluded from this analysis.
All ruptured devices were included in the analysis. These devices were compared to a non-ruptured group, which was limited to devices where explantation/MRI date was greater than 146 days. This timeframe was selected because it aligned with the earliest number of days to occurrence within the ruptured group. The purpose was to have comparable data whereby there was a minimum implantation time prior to the diagnosis of rupture. The prevalence of rupture was evaluated for each patient as well as surgical and postsurgical characteristics. Statistical association was determined using a GEE model adjusted for variables found to be individually significant. The difference between clinical and statistical significance has been widely discussed. It is important to note, "clinically significant" is not dependent on the amount of the p-value; correlations and findings are often "clinically significant" without being "statistically significant". 3, 4 For the purposes of this article, clinical significance has been defined as a difference ≥2%, and the threshold for statistical significance was set at p ≤ .05. The distribution of prior MRI results within the ruptured group was also assessed using a frequency distribution. Finally, the prevalence of rupture and various patient/surgical characteristics were calculated by individual surgeon to examine surgeon-specific techniques.
RESULTS
Patients
The median patient age at the time of enrollment was 38 years (range: 18-71) with the majority of patients being Caucasian and married, and 37% having an annual household income that exceeded $80,000. The median body mass index was 20.8 (range: 15.9-35.0). The majority of
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Aesthetic Surgery Journal 35(S1) patients had completed some college education with 45% holding at least a Bachelor's degree and 8% having completed postgraduate level education. The implants included in this analysis (Table 1) had a median size of 360 cc (range: 175 cc-700 cc). Surface characteristics included a smooth shell (52%) and a textured shell (48%). Round devices were used in 86% and shaped devices in 14%. The incision site was inframammary in 64% and periareolar in 30%. Device location was submuscular in 56% and subglandular in 44%. The majority of surgeons (21/31) placed smooth surface devices through an inframammary incision. Four surgeons completed implant placement with the transaxillary approach.
The ruptured devices (N = 43) identified in these patients were implanted a median time of 7.0 years (range: 147 days-10.2 years). The non-ruptured devices (N = 1749) were implanted a median time of 6.6 years (range: 148 days-10.6 years).
Identification of Ruptures
Sixteen of the 31 investigators identified 43 ruptured devices. Ten of the devices were identified via MRI and have not yet been explanted. Nine of the ruptured devices were identified at explantation and did not have MRIs prior to explantation. The remaining 24 devices underwent MRI prior to explantation. Table 2 reports the MRI findings for these explants. Almost half of the MRI scans within the ruptured group (45.8%) were read by both radiologists as having definitive evidence of rupture. Seven MRI scans had inconsistent radiologist findings prior to explantation of the ruptured device. Of the 43 device ruptures, 21 were in the MRI cohort and 22 were in the non-MRI cohort.
Two of the 43 ruptured devices were classified as symptomatic. One patient reported that her breast implant "felt different" and the other reported pain. These implants were found to be ruptured at explantation. Figure 2 depicts an MRI scan read by both radiologists as having definitive evidence of rupture; the devices were explanted 49 days after the scan and rupture was confirmed. Figure 3 depicts an MRI scan first read by both radiologists as ruptured and later cleared of rupture on the second scan. Upon removal, the physician noted a small puncture on the implant with minimal presence of gel outside the shell within the capsule. Figure 4 shows this device as a pictorial example of one of the modes of failure. The analysis from device retrieval suggests flex fatigue as the likely cause of failure as there are no definitive striations, uniform markings, or any other features that suggest otherwise.
Characteristics of Ruptured vs Non-Ruptured Implants Table 3 describes the incidence of rupture. Overall the rupture prevalence for this study was 2.4% through an average follow-up of 6.6 years. Rupture was reported in 0.4% of the shaped devices and 2.7% of the round devices. Rupture was also reported in 0.8% of textured surface devices (round and shaped) and in 3.8% of smooth surface devices. Rupture was reported in 5.5% of the devices that received steroid pocket irrigation compared to 1.8% of the devices that did not receive steroid pocket irrigation. Rupture was reported in 1.1% of devices that were placed in the subglandular position while for those in the submuscular position rupture was reported at 3.4%. Other variables that resulted in a difference >2% were: incision site, incision size, and massage. Although multivariate analysis did not identify any statistically significant associations (p >.05), the following characteristics had the strongest association with ruptured devices: steroid pocket irrigation (p = .0520), device surface (p = .0549), and device placement (p = .2650). The remaining characteristics had p-values >.3463.
Surgeon-Focused Analyses
The surgeon-specific incidence of rupture as related to surgical and postoperative practices was reviewed. Three surgeons accounted for over 51% of the reported ruptures but enrolled only 15% of the devices (Table 4) . Each of these three surgeons reported a greater than 8% rupture, while all other remaining surgeons reported rates of 6.3% or less. This review revealed differences in device/surgical practices between these three surgeons and the remaining 28 surgeons with less rupture. These three surgeons employed only round devices (100%) and utilized smooth devices for over 99% of their implantations. Regarding the remaining characteristics that were identified as having an impact (>2% in Table 3 ), these surgeons more often employed techniques associated with higher rupture. Specifically, pocket irrigation with steroid was done with 61% of the devices implanted by these surgeons compared to 9% usage by other surgeons. The surgeons with greater than 8% rupture employed submuscular placement with over 93% of their devices, whereas the other surgeons employed submuscular placement with only 49% of their devices. Similarly, the surgeons with higher rupture recommended massage (99%) more often than other surgeons (41%). 
S36
Aesthetic Surgery Journal 35(S1) Regarding incision site and size, these surgeons did transaxillary incisions (37%) and 0-3 cm incisions (26%) more often than other surgeons (<1% and 15%, respectively). Almost all transaxillary incisions in this study were done by the surgeons with higher rupture rates; surgeons with lower rates only placed five total devices using transaxillary incisions. Furthermore, 88% of the devices placed with transaxillary incisions were round, smooth, and placed submuscularly and with general anesthesia, betadine, and steroids. Massage and surgical bra was also recommended for over 90% of these patients.
DISCUSSION
This study demonstrates that rupture is relatively a rare occurrence and likely due to its various etiologies. It is not associated with the factors that are typically investigated to determine relationships between breast implants and other studied adverse events (ie, infection, capsular contracture). These fifth generation implants are inert and consist of High-Strength Cohesive silicone gel and a low bleed barrier elastomer shell. 5 The shells are designed to be unaffected by patient tissue characteristics, operative technique, and operative solutions (ie, antibiotics, steroids). However, the results from this analysis demonstrate that certain surgical characteristics are related to device rupture.
Although the characteristics investigated were not statistically significant, some are considered clinically significant. Some specific characteristics emerged as correlated with higher rupture in the overall results and were also confirmed within the subset of surgeons with greater than 8% rupture rates. Rupture prevalence was lower among textured devices compared to smooth (0.8% vs 3.8%, respectively). This is consistent with the protective effect that the TrueTexture™ surface has demonstrated against capsular contracture. Contrary to the current school of thought, rupture was not more common among patients with prior capsular contracture compared to patients without previous capsular contracture (3.4% vs 2.3%, respectively). However, further study of the correlation of capsular contracture as a precursor to rupture is warranted.
The results found a lower prevalence of rupture among devices placed subglandularly (1.1%) compared to those placed submuscularly (3.4%). The authors hypothesize that implants placed subglandularly are not subject to the deforming force of the muscle and, therefore, may sustain 
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Aesthetic Surgery Journal 35(S1) less folding of the implant edge. The muscle inherently contracts over the implant exerting more force across the device and causing more fold wear over time. It would then be expected that fold fatigue in the submuscular position would occur more often than in the subglandular plane. However, with both placements, a highly cohesive fifth generation gel adds to implant stability, which should result in less folding overall, hence less wear areas and a lower rupture rate. The low rupture rates seen in this study may in part be attributed to the High-Strength Cohesive silicone gel fill which has been shown 6 to be the strongest currently available on the market in the United States.
The prevalence of rupture was 7.8% among devices placed with a transaxillary incision site compared to 1.6% Prevalence estimates indicate clinically meaningful differences. and 3.0% when an inframammary or periareolar approach was utilized. Although a large difference in prevalence is apparent, the transaxillary sample size was small (N = 102 out of 1792) and possibly influenced by the four surgeons who employed this technique (97 implanted devices by a single surgeon). Although an impact analysis was not within the scope of this study, it is likely that exclusion of the transaxillary approaches would only have a minimal impact among characteristics with large sample sizes (eg, round (n = 1539), smooth (n = 936)), yet the impact is unknown for characteristics with smaller sample sizes (eg, betadine (n = 287) and steroids (n = 292)). Povidoneiodine is contraindicated for all three U.S. manufacturers, [7] [8] [9] though there is research to suggest that povidone-iodine has no significant impact on tensile strength. 10 Regarding the surgeon-focused analysis, an important finding of this study is that three surgeons accounted for over 51% of the ruptures and enrolled only 15% of the patients. This largely disproportionate distribution of rupture further supports the technique-dependent variable of this 
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complication. This highlights the need for further analysis/ assessment as some of these factors are controllable via best surgical practices. It is important to highlight that of the 43 ruptured devices only two were classified as symptomatic ("felt different" and pain). The remaining 41 ruptured devices were asymptomatic (95.3%) and include 10 devices (24.4%) that have not yet been explanted. The large number of asymptomatic patients in this sample corroborates studies on long-term untreated silicone implant rupture, which have found that implant rupture is rarely symptomatic.
11,12
Although manufacturer's guidance is to remove any device suspected of rupture, the surgeon's clinical determination to explant an asymptomatic rupture is widely variable depending on patient preference with the consideration that implant rupture may be relatively harmless. 12 Figure 5 depicts a patient's MRI scan read as ruptured by both local and central radiologists, but confirmed nonruptured at explant. The surgeon noted and removed freefloating silicone from the patients' previous implant in the pocket, which led to the false positive read. The dependence on MRI diagnosis remains a paradoxical discussion because the high cost can be prohibitive to many breast implant patients. 13, 14 While the potential for false positive reads and MRI costs remain a consideration, MRIs are currently the most accurate diagnostic tool for silent rupture 13, 15, 16 and are recommended by all U.S. manufacturers.
7-9
Limitations
Interpretations of the results in this analysis should be considered with care due to sample size and study design limitations. Despite the large overall study population, the sample included very few ruptures and, therefore, the sample was not powered sufficiently to detect statistical differences. Regarding study design, this prospective cohort did not stratify to enroll specific surgical characteristic randomly or equally across surgeons. Therefore, only a small number of the implants in this analysis were placed with a transaxillary incision, and over 95% were placed by a single surgeon. This limitation causes results from analyses regarding the transaxillary incision site to possibly be biased due to the single surgeon. Regarding other possible biases introduced by specific surgeons, the authors recognize that an impact analysis, excluding the three surgeons that accounted for over 50% of ruptures, may have been beneficial. However, the analysis was not performed due to the smaller rupture sample size that would have resulted from the exclusion. Lastly, while MRI scans are one of the best diagnostic tools for silent rupture, the variability in read interpretations as well as the small potential for false positives, may limit the conclusions of this analysis.
CONCLUSION
The occurrence of rupture is relatively uncommon but continues to concern both patients and plastic surgeons. Even with a very large sample size, the number of ruptures that occurred with the Sientra fifth generation devices was too low to detect statistically significant associations between factors and rupture. However, a strong trend for association with certain factors emerged. Lower rupture rates were seen with the utilization of textured devices, an inframammary approach, and subglandular placement. Future research is needed to help definitively determine characteristics that may affect implant rupture, however the results presented here provide visibility and demonstrate trends for the impacts that patient, device, and surgical characteristics play in the occurrence of rupture.
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